[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2008 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
27-Feb-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2008
Quarter
31-Dec-2008 [#4]
Profit Trend
QoQ- 6.58%
YoY- 19.87%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
Revenue 1,302,520 1,293,856 1,254,864 1,305,646 1,303,204 1,326,230 1,238,600 3.40%
PBT 71,930 89,042 80,736 90,599 88,137 96,924 109,496 -24.41%
Tax -19,116 -22,610 -21,964 -29,190 -30,154 -32,046 -33,568 -31.27%
NP 52,814 66,432 58,772 61,409 57,982 64,878 75,928 -21.47%
-
NP to SH 51,038 64,438 58,088 60,031 56,322 63,304 74,180 -22.04%
-
Tax Rate 26.58% 25.39% 27.20% 32.22% 34.21% 33.06% 30.66% -
Total Cost 1,249,705 1,227,424 1,196,092 1,244,237 1,245,221 1,261,352 1,162,672 4.92%
-
Net Worth 407,610 400,063 402,378 388,297 374,390 362,623 367,905 7.06%
Dividend
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
Div 38,514 57,763 - 28,881 25,672 38,508 - -
Div Payout % 75.46% 89.64% - 48.11% 45.58% 60.83% - -
Equity
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
Net Worth 407,610 400,063 402,378 388,297 374,390 362,623 367,905 7.06%
NOSH 106,984 106,968 107,015 106,968 106,968 106,968 106,949 0.02%
Ratio Analysis
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
NP Margin 4.05% 5.13% 4.68% 4.70% 4.45% 4.89% 6.13% -
ROE 12.52% 16.11% 14.44% 15.46% 15.04% 17.46% 20.16% -
Per Share
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
RPS 1,217.49 1,209.56 1,172.60 1,220.58 1,218.30 1,239.83 1,158.12 3.38%
EPS 47.71 60.24 54.28 56.12 52.65 59.18 69.36 -22.05%
DPS 36.00 54.00 0.00 27.00 24.00 36.00 0.00 -
NAPS 3.81 3.74 3.76 3.63 3.50 3.39 3.44 7.04%
Adjusted Per Share Value based on latest NOSH - 106,969
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
RPS 90.37 89.77 87.07 90.59 90.42 92.02 85.94 3.40%
EPS 3.54 4.47 4.03 4.17 3.91 4.39 5.15 -22.09%
DPS 2.67 4.01 0.00 2.00 1.78 2.67 0.00 -
NAPS 0.2828 0.2776 0.2792 0.2694 0.2598 0.2516 0.2553 7.05%
Price Multiplier on Financial Quarter End Date
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
Date 30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 -
Price 4.09 3.80 3.45 3.36 3.24 3.27 2.95 -
P/RPS 0.34 0.31 0.29 0.28 0.27 0.26 0.25 22.72%
P/EPS 8.57 6.31 6.36 5.99 6.15 5.53 4.25 59.54%
EY 11.66 15.85 15.73 16.70 16.25 18.10 23.51 -37.31%
DY 8.80 14.21 0.00 8.04 7.41 11.01 0.00 -
P/NAPS 1.07 1.02 0.92 0.93 0.93 0.96 0.86 15.66%
Price Multiplier on Announcement Date
30/09/09 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 CAGR
Date 13/11/09 21/08/09 08/05/09 27/02/09 24/11/08 14/08/08 28/05/08 -
Price 3.93 4.00 3.82 2.73 3.35 3.44 3.45 -
P/RPS 0.32 0.33 0.33 0.22 0.27 0.28 0.30 4.39%
P/EPS 8.24 6.64 7.04 4.86 6.36 5.81 4.97 40.03%
EY 12.14 15.06 14.21 20.56 15.72 17.20 20.10 -28.52%
DY 9.16 13.50 0.00 9.89 7.16 10.47 0.00 -
P/NAPS 1.03 1.07 1.02 0.75 0.96 1.01 1.00 1.98%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment